Breaking News Instant updates and real-time market news.

ACB

Aurora Cannabis

$4.10

-0.05 (-1.20%)

, CGC

Canopy Growth

$22.61

-0.12 (-0.53%)

13:46
10/09/19
10/09
13:46
10/09/19
13:46

Roth says low enthusiasm for cannabis stocks doesn't reflect industry potential

Roth Capital analyst Scott Fortune noted that stocks in the cannabis sector have declined during the six months since the first quarter with the industry "mired in a capital crunch, with a vape crisis to make matters worse." However, he thinks the recently lower enthusiasm for cannabis stocks does not reflect the cannabis industry's prospects, as he still sees a lot of upside potential. A "meaningful shift" in investor focus to operational execution has led to a short-term correction in valuations, but the industry is still projected to grow at a 27% compound annual growth rate for the next three years, said Fortune, who advises that investors focus for now on companies with strong balance sheets and positive adjusted EBITDA who are nearing break even. Publicly traded companies in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), and Trulieve Cannabis (TCNNF).

ACB

Aurora Cannabis

$4.10

-0.05 (-1.20%)

CGC

Canopy Growth

$22.61

-0.12 (-0.53%)

CRON

Cronos Group

$8.60

0.07 (0.82%)

TLRY

Tilray

$23.85

-0.12 (-0.50%)

CNTTF

CannTrust Holdings

$0.00

(0.00%)

APHA

Aphria

$5.32

0.035 (0.66%)

TCNNF

Trulieve Cannabis

$0.00

(0.00%)

  • 15

    Oct

  • 12

    Nov

  • 12

    Nov

ACB Aurora Cannabis
$4.10

-0.05 (-1.20%)

09/24/19
CIBC
09/24/19
INITIATION
CIBC
Neutral
Aurora Cannabis initiated with a Neutral at CIBC
CIBC analyst John Zamparo started Aurora Cannabis with a Neutral rating and C$7 price target. The company's Canadian market share leadership and early international success "provide encouragement," but its lack of U.S. exposure, continued capital allocation towards cultivation, and a balance sheet "in need of support "limit optimism on the shares, Zamparo tells investors in a research note.
09/20/19
MKMP
09/20/19
INITIATION
MKMP
Sell
MKM Partners starts Aurora Cannabis at Sell on cultivator profit difficulties
As previously reported, MKM Partners analyst Bill Kirk initiated Aurora Cannabis with a Sell rating and C$5 price target, telling investors that he believes profitability for cultivators will generally get worse before getting better given that supply will continue to grow and pricing is already decreasing. The analyst, who also sees the company's outsized exposure to medical marijuana limiting its growth opportunity, believes Aurora will need to raise some capital before it is able to show positive EBITDA.
CGC Canopy Growth
$22.61

-0.12 (-0.53%)

09/27/19
BOFA
09/27/19
DOWNGRADE
Target $27
BOFA
Neutral
BofA/Merrill downgrades Canopy Growth to Neutral on second half 'flattening'
BofA Merrill Lynch analyst Christopher Carey downgraded Canopy Growth to Neutral from Buy and cut his price target on the New York traded shares to $27 from $46 as he cut his multiple in half to 10 times EV/sales. While he still sees Canopy as a long-term leader in the cannabis industry, he thinks Canada industry growth is set to pause in the second half and potentially flatten, which he thinks could also be the case with Canopy. However, consensus is modeling strong quarter-over-quarter double-digit sales growth, noted Carey. The analyst, who sees too much risk to the stock until estimates are recalibrated, also thinks news about vaping could keep impacting cannabis sector sentiment in the near-term.
09/27/19
09/27/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Box (BOX) downgraded to Underweight from Neutral at JPMorgan with analyst Mark Murphy saying while the stock has run higher, competition is intensifying in Box's target markets. 2. Atara Biotherapeutics (ATRA) downgraded to Sell from Neutral at Goldman Sachs with analyst Salveen Richter saying he sees a lack of near-term catalysts for the stock and questions surrounding the company's clinical programs. 3. Carnival (CCL) downgraded to Sell from Hold at Berenberg and to Neutral from Buy at UBS. 4. eBay (EBAY) and Booking Holdings (BKNG) downgraded to Market Perform from Outperform at Wells Fargo. 5. Canopy Growth (CGC) downgraded to Neutral from Buy at BofA/Merrill with analyst Christopher Carey saying while he still sees Canopy as a long-term leader in the cannabis industry, he thinks Canada industry growth is set to pause in the second half and potentially flatten, which he thinks could also be the case with Canopy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/01/19
PIPR
10/01/19
NO CHANGE
Target $40
PIPR
Overweight
Canopy Growth price target lowered to $40 from $49 at Piper Jaffray
Piper Jaffray analyst Michael Lavery lowered his price target for Canopy Growth to $40 from $49 to reflect near-term risks from a slower retail rollout in Ontario and risks to vapor sales from recent headlines. The analyst, however, keeps an Overweight rating on the shares despite a reduced sales outlook. He expects Canopy's new management to bring a more disciplined approach to spending and capital allocation that should help the company to continue to grow without needing new capital. Further, the company's capital position is a "key differentiator in the industry," says Lavery. He believes the company is well positioned with $2.3B in cash and equivalents.
CRON Cronos Group
$8.60

0.07 (0.82%)

10/07/19
BOFA
10/07/19
NO CHANGE
BOFA
Cannabis consensus estimates still may be 30% too high, says BofA/Merrill
BofA Merrill Lynch analyst Christopher Carey thinks that valuations across the cannabis sector are looking more reasonable following the selloff since April, though he still believes consensus estimates for the group are likely at least 30% too high. Given this view, he is of the opinion that the true "buy" signal for the sector won't come until sales estimates are significantly recalibrated. Though individual companies could gain share, on an industry level, sales estimates are too high, contends Carey, who thinks the stocks in the group could remain volatile for some time. He prefers Cronos Group (CRON), which he thinks stands out "as an especially attractive buying opportunity" following the group's pullback, Carey tells investors. He keeps a Buy rating on Cronos, has Neutral ratings on Aurora Cannabis (ACB) and Canopy Growth (CGC) and maintains an Underperform rating on HEXO Corp (HEXO).
09/26/19
COMP
09/26/19
NO CHANGE
COMP
Cannabis banking bill should find path to passage in Senate, says Compass Point
After the House of Representatives cleared the SAFE Banking Act by a vote of 321 to 103, Compass Point analyst Isaac Boltansky said the bipartisan clearance of the cannabis banking bill should be viewed as a tailwind for the bill's prospects in the Senate and he continue to think it will find "a path to passage" as part of a broader legislative package. He thinks that the SAFE Act will expand access to banking services for legal cannabis operators, but cautions that any immediate expansion is likely to be modest. Publicly traded companies in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY), and Trulieve Cannabis (TCNNF).
09/20/19
MKMP
09/20/19
INITIATION
MKMP
Neutral
MKM Partners starts Cronos Group at Neutral with C$14 price target
As previously reported, MKM Partners analyst Bill Kirk initiated Cronos Group (CRON) with a Neutral and C$14 price target, citing his view that the company is wise to build an intellectual property moat around its brands rather than focus on cultivation. Cronos has strong branded and distribution advantages and a strong infrastructure partner in Altria (MO) and Kirk sees the company as unlikely to ultimately grow its raw materials, stating that he believes the "odds better favor Cronos" although the path to brand differentiation is "long and unpredictable."
09/19/19
MKMP
09/19/19
INITIATION
MKMP
Neutral
Cronos Group initiated with a Neutral at MKM Partners
MKM Partners analyst Bill Kirk initiated Cronos Group with a Neutral and C$14 price target.
TLRY Tilray
$23.85

-0.12 (-0.50%)

09/20/19
MKMP
09/20/19
INITIATION
MKMP
Neutral
MKM Partners starts Tilray at Neutral, says consensus too high
As previously reported, MKM Partners analyst Bill Kirk initiated Tilray with a Neutral rating and $34 price target. While he likes the company's strategy in terms of entering the U.S. via hemp seed food products and cultivating in Portugal to service European markets, he also thinks FY20 consensus estimates are still too high. He also thinks profitability for Canadian cultivation will get worse before it gets better, as he believes flower and production for extraction will get commoditized.
08/23/19
COWN
08/23/19
NO CHANGE
Target $150
COWN
Outperform
Tilray top-line progression keeps us constructive, says Cowen
Cowen analyst Vivien Azer met with Tilray management following impressive Q2 results. The analyst admitted the company's cash use is high but said the company is making investments to reach its goal if becoming a global leader with cannabis. He believes the company could look to raise capital in the back half of 2020 but is comforted by management's expectations for Canada profitability sometime in the quarter or so. Azer reiterated her Outperform rating and $!50 price target on Tilray shares.
09/19/19
MKMP
09/19/19
INITIATION
Target $34
MKMP
Neutral
Tilray initiated with a Neutral at MKM Partners
MKM Partners analyst Bill Kirk initiated Tilray with a Neutral and $34 price target.
CNTTF CannTrust Holdings
$0.00

(0.00%)

02/25/19
02/25/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Antares Pharma (ATRS) initiated with an Outperform at Cowen. 2. New Fortress Energy (NFE) initiated with a Buy at Citi and Stifel, an Overweight at Morgan Stanley, an Equal Weight at Barclays and an Oupterform at JMP Securities and Evercore ISI. 3. Aurora Cannabis (ACB), CannTrust Holdings (CNTTF), Flowr (FLWPF), Organigram (OGRMF) and The Green Organic Dutchman (TGODF) initiated with a Buy at Jefferies, Canopy Growth (CGC) and Emerald Health Therapeutics (EMHTF) initiated with a Hold, Cronos Group (CRON) and HEXO (HEXO) initiated with an Underperform. 4. Pulse Biosciences (PLSE) initiated with a Buy at H.C. Wainwright. 5. Beacon Roofing (BECN) initiated with a Neutral at Buckingham, while the firm initiated BMC Stock Holdings (BMCH) and TopBuild (BLD) with a Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/10/19
PIPR
06/10/19
NO CHANGE
PIPR
Cannabis regulation could become top 2020 election issue, says Piper Jaffray
After Washington D.C. lobbyist Michael Esposito, who also works closely with President Trump's administration, spoke at his firm's conference, Piper Jaffray analyst Michael Lavery believes cannabis regulation could become a top 2020 election issue. By supporting cannabis, Trump may be able to incrementally broaden his appeal with swing voters without alienating his base, Esposito tells investors in a research note. Though Trump has indicated his willingness to support the STATES Act, his enthusiasm could depend on whether or not Elizabeth Warren, author of the bill, is his opponent, adds the analyst in a note titled "Handicapping US Legalization Outlook: Politics Are Complicated." And while Senate Majority Leader Mitch McConnell is a roadblock for legislation in the Senate, Trump could use executive orders between now and the election to show support for the industry, potentially relating to cannabis banking or medical research, says Lavery. The analyst has Overweight ratings on both Canopy Growth (CGC) and Tilray (TLRY). Other names in the space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), MediPharm Labs (MLCPF) and Zynerba (ZYNE).
03/14/19
COWN
03/14/19
NO CHANGE
COWN
Narrow U.S. cannabis bills have better prospects than broad ones, says Cowen
Cowen analyst Jaret Seiberg said it is hard for him to see a scenario in the 116th Congress in which Senate Majority Leader Mitch McConnell holds a vote on legislation to fully legalize cannabis, as too many senators see no political upside for McConnell to schedule such a vote. Given this view, Seiberg believes that prospects are better for narrower bills that could get attached to spending packages and other measures than for broader bills that would legalize recreational use. Of the narrower bills introduced in the U.S. so far, Seiberg believes the SAFE Act on cannabis banking has the best shot before the 2020 election. Publicly traded companies in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), Canopy Growth (CGC), Cronos Group (CRON), General Cannabis (CANN), India Globalization Capital (IGC), MediPharm Labs (MLCPF) and Tilray (TLRY).
APHA Aphria
$5.32

0.035 (0.66%)

07/26/19
CIBC
07/26/19
DOWNGRADE
CIBC
Underperformer
Aphria downgraded to Underperformer from Neutral at CIBC
CIBC analyst John Zamparo downgraded Aphria to Underperformer from Neutral and lowered his price target for the shares to $6.50 from $12. The stock closed Thursday down 23c to $5.84. The analyst cites concerns about "aggressive" Street estimates, potential asset impairment, a "leadership void and less robust supply contracts" for the downgrade. While Aphria likely captures a high-single-digit market share, and last month's partnership with PAX Era was a "meaningful win," the stock carries more risk than reward at current levels, Zamparo tells investors in a research note. The analyst believes consensus estimates need to come down to reflect slower industry growth than previously contemplated. He thinks this will pressure the stock.
05/24/19
05/24/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zoom Video (ZM) initiated with a Perform at Oppenheimer. 2. CannTrust (CTST) initiated with a Buy at BofA/Merrill. 3. Inseego (INSG) initiated with an Outperform at Cowen. 4. Falcon Minerals (FLMN) initiated with an Outperform at Baird. 5. Aphria (APHA) initiated with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TCNNF Trulieve Cannabis
$0.00

(0.00%)

09/12/19
COMP
09/12/19
INITIATION
Target $9
COMP
Neutral
Trulieve Cannabis initiated with a Neutral at Compass Point
Compass Point analyst Rommel Dionisio initiated Trulieve Cannabis with a Neutral and $9 price target. Trulieve is the first licensed cannabis producer in Florida, and the current cap on the number of dispensaries in Florida is set to expire in April 2020, the analyst wrote in a note to investors. Dionisio believes Trulieve's leading market share could come under "severe pressure" and said incremental growth outside of Florida might not be enough to offset market shares losses within Florida.

TODAY'S FREE FLY STORIES

CNC

Centene

$48.49

-0.28 (-0.57%)

11:05
10/23/19
10/23
11:05
10/23/19
11:05
Options
Centene call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

D

Dominion

$83.07

0.29 (0.35%)

11:03
10/23/19
10/23
11:03
10/23/19
11:03
Hot Stocks
Dominion, Smithfield Foods double investment in renewable natural gas to $500M »

Dominion Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

BA

Boeing

$345.52

8.07 (2.39%)

11:02
10/23/19
10/23
11:02
10/23/19
11:02
Hot Stocks
Boeing CFO says it will take 'several quarters' to deliver parked 737 MAX jets »

CFO Greg Smith says it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$345.79

8.34 (2.47%)

11:00
10/23/19
10/23
11:00
10/23/19
11:00
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing says studying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MMM

3M

$166.93

-0.63 (-0.38%)

10:55
10/23/19
10/23
10:55
10/23/19
10:55
Options
3M put volume heavy and directionally bearish »

Bearish flow noted in 3M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GLOG

GasLog

$14.29

0.325 (2.33%)

, GLOP

GasLog Partners

$20.24

0.35 (1.76%)

10:55
10/23/19
10/23
10:55
10/23/19
10:55
Conference/Events
Deutsche Bank shipping analyst to hold analyst/industry conference call »

Analysts, along with…

GLOG

GasLog

$14.29

0.325 (2.33%)

GLOP

GasLog Partners

$20.24

0.35 (1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 06

    Nov

BA

Boeing

$346.26

8.81 (2.61%)

10:54
10/23/19
10/23
10:54
10/23/19
10:54
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$346.90

9.45 (2.80%)

10:53
10/23/19
10/23
10:53
10/23/19
10:53
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing sees first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

FCX

Freeport McMoRan

$9.98

0.06 (0.60%)

10:51
10/23/19
10/23
10:51
10/23/19
10:51
Hot Stocks
Freeport McMoRan says current copper prices not sustainable »

Management said the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$347.23

9.78 (2.90%)

10:50
10/23/19
10/23
10:50
10/23/19
10:50
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing: US-China trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UXIN

Uxin

$2.68

-0.04 (-1.47%)

10:47
10/23/19
10/23
10:47
10/23/19
10:47
Downgrade
Uxin rating change  »

JPMorgan downgrades Uxin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$348.24

10.79 (3.20%)

10:43
10/23/19
10/23
10:43
10/23/19
10:43
Hot Stocks
Boeing CEO says may consider further 737 rate reductions, line shutdown »

Says should the estimate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$348.52

11.07 (3.28%)

10:41
10/23/19
10/23
10:41
10/23/19
10:41
Hot Stocks
Boeing expects to maintain current production rate for 737 MAX »

Expects to maintain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

KRE

SPDR S&P Regional Banking ETF

$53.96

-0.2 (-0.37%)

10:40
10/23/19
10/23
10:40
10/23/19
10:40
Options
Size put spread in Regional Banking ETF rolls long puts to higher strike »

Size put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
10/23/19
10/23
10:40
10/23/19
10:40
General news
Energy Action: WTI crude »

Energy Action: WTI crude…

BA

Boeing

$349.46

12.01 (3.56%)

10:37
10/23/19
10/23
10:37
10/23/19
10:37
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.60

12.15 (3.60%)

10:36
10/23/19
10/23
10:36
10/23/19
10:36
Hot Stocks
Boeing: FAA, others will ultimately determine timing of MAX return to service »

Says return to service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.40

11.95 (3.54%)

10:35
10/23/19
10/23
10:35
10/23/19
10:35
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing says sees approval…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HOG

Harley-Davidson

$39.46

-0.57 (-1.42%)

10:35
10/23/19
10/23
10:35
10/23/19
10:35
Options
Harley Davidson put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
10/23/19
10/23
10:35
10/23/19
10:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

BA

Boeing

$349.81

12.36 (3.66%)

10:35
10/23/19
10/23
10:35
10/23/19
10:35
Hot Stocks
Boeing says has conducted more than 800 tests in production flights »

Says has conducted more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.65

12.2 (3.62%)

10:34
10/23/19
10/23
10:34
10/23/19
10:34
Hot Stocks
Boeing CEO says 'regrets' difficulties that release of IM document has presented »

Says "understands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BA

Boeing

$349.52

12.07 (3.58%)

10:33
10/23/19
10/23
10:33
10/23/19
10:33
Hot Stocks
Boeing CEO says 737 MAX accidents 'weigh heavily on us' »

Sys "nothing is more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

USO

United States Oil Fund

$11.37

0.025 (0.22%)

10:30
10/23/19
10/23
10:30
10/23/19
10:30
General news
Crude inventories for week of October 18 »

Crude oil inventories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAVE

Spirit Airlines

$36.89

-0.36 (-0.97%)

, EADSY

Airbus

$0.00

(0.00%)

10:29
10/23/19
10/23
10:29
10/23/19
10:29
Periodicals
Breaking Periodicals news story on Spirit Airlines, Airbus »

Spirit Airlines near deal…

SAVE

Spirit Airlines

$36.89

-0.36 (-0.97%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.